HARVARD BIOSCIENCE INC Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Harvard Bioscience Inc quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Harvard Bioscience Inc Return On Equity for the quarter ending June 30, 2024 was -15.1 %, a 104% decline year-over-year.
  • Harvard Bioscience Inc annual Return On Equity for 2023 was -4.6 %, a 64% increase from 2022.
  • Harvard Bioscience Inc annual Return On Equity for 2022 was -12.8 %, a 3405% decline from 2021.
  • Harvard Bioscience Inc annual Return On Equity for 2021 was -0.36 %, a 96.5% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -4.6 +8.17 +64% Jan 1, 2023 Dec 31, 2023
2022 -12.8 -12.4 -3405% Jan 1, 2022 Dec 31, 2022
2021 -0.36 +9.85 +96.5% Jan 1, 2021 Dec 31, 2021
2020 -10.2 -4.34 -74% Jan 1, 2020 Dec 31, 2020
2019 -5.87 -2.22 -60.8% Jan 1, 2019 Dec 31, 2019
2018 -3.65 -2.52 -223% Jan 1, 2018 Dec 31, 2018
2017 -1.13 +4.56 +80.2% Jan 1, 2017 Dec 31, 2017
2016 -5.69 +15.6 +73.3% Jan 1, 2016 Dec 31, 2016
2015 -21.3 -23.8 -975% Jan 1, 2015 Dec 31, 2015
2014 2.44 +4.21 Jan 1, 2014 Dec 31, 2014
2013 -1.78 -4.14 -175% Jan 1, 2013 Dec 31, 2013
2012 2.37 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.